Article
The challenge to global acceptance of Part 3 of ISO 10993.
Medical device technology - 1 Jun 2006
Carraway J, Ghosh C
Abstract excerpt
ISO 10993, Part 3: Testing for Genotoxicity, Carcinogenicity and Reproductive Effects, is not a globally recognised standard. The differences in these testing requirements in Europe, the United States and Japan are explained together with guidance on when to test and efficient strategies to adopt when marketing products in these regions.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
